Skip to main content

Court OKs Benitec s Request to Dismiss Patent Lawsuit Against Nucleonics

NEW YORK, Oct. 4 (GenomeWeb News) - A court has dismissed Benitec's RNA interference patent infringement lawsuit with Nucleonics at Benitec's request, the company said today.

 

Benitec filed a motion with the US District Court for the District of Delaware to dismiss the suit after a recent Supreme Court decision in an unrelated case brought Nucelonics' drug development activities within the "safe harbor" exemption of drug development. Benitec said it filed the motion because "no case or controversy existed" anymore.

 

Benitec sued Nucleonics in March 2004 for infringing its US Patent No. 6,573,099.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.